Prostate Cancer Coverage from Every Angle
Advertisement
Advertisement

Recent News

Targeted Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer
Initiative to Reduce Narcotic Prescribing in Robotic Radical Prostatectomy
Interim Scan During Radioligand Therapy for Men With Advanced Prostate Cancer
ASCO 2019: TOPARP-B Trial of Olaparib in Castration-Resistant Prostate Cancer
ASCO 2019: Comparing First-Line Treatments in Poor-Prognosis Metastatic Prostate Cancer
ASCO 2019: Adding Apalutamide to Androgen-Deprivation Therapy in Prostate Cancer
ASCO 2019: Does Adding Abiraterone Acetate to Enzalutamide Improve Outcomes in Metastatic Prostate Cancer?
ASCO 2019: Quality-of-Life Outcomes With Darolutamide in Prostate Cancer
FDA Grants Fast Track Designation to ARV-110 in Metastatic Castration-Resistant Prostate Cancer
New Prognostic Marker Under Study in Metastatic Prostate Cancer
ASCO 2019: Overall Survival With or Without Enzalutamide for Prostate Cancer
Which Genomic Alterations Are Linked to Poor Outcomes in Advanced Prostate Cancer?
AUA 2019: Androgen-Deprivation Therapy and Risk to Cognitive Health
AUA 2019: Can a Beta-Blocker Impact the Risk of Prostate Cancer?
AUA 2019: Targeted Versus Systemic Biopsy for Diagnosing Prostate Cancer
ESTRO 2019: High-Dose-Rate Monotherapy for Localized Prostate Cancer
Darolutamide Granted NDA and Priority Review in Nonmetastatic Castration-Resistant Prostate Cancer
Predicting Adverse Prostate Cancer Pathology With Genetic Assay
Prostate Cancer’s Genetic Relationship to Other Cancers
Novel Antibody-Drug Conjugate in Castration-Resistant Prostate Cancer
Should Docetaxel Be Added to ADT in High-Risk Prostate Cancer?
Tumor-Lysis Syndrome in Patients With Genitourinary Cancers
Does Sipuleucel-T Improve Survival in African Americans With Advanced Prostate Cancer?
EAU Congress 2019: Compounds Found in Coffee May Inhibit Growth of Prostate Cancer Cells
AACR 2019: Abiraterone Acetate and Preexisting Cardiovascular Disease in Patients With Prostate Cancer
Targeting Fatty Acid Transporter to Prevent Disease Progression in Prostate Cancer
2019 ASCO-SITC: Genetic Characterization of BRCA-Mutant Prostate Cancer
2019 GU Symposium: Survival May Vary by Race in Some Patients Treated for Prostate Cancer
2019 GU Symposium: Nivolumab Plus Ipilimumab in Metastatic Castration-Resistant Prostate Cancer
2019 GU Symposium: Novel Radiolabeled Therapy for Resistant Prostate Cancer
Prostate Cancer Outcomes: Evaluation of Gleason Score and Race
Use of Finasteride and Prostate Cancer–Specific Mortality
Germline DNA Repair Mutations and Prognosis in Castration-Resistant Prostate Cancer
Outcomes After Radical Prostatectomy: Very High–Risk vs. High-Risk Patients


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.